Eurofins agrees to buy Element Materials' North American life sciences testing services for $400 million

• Eurofins agreed to buy Element Materials Technology’s Life Sciences Testing Services business in North America for an enterprise value of USD 400 million.
• Business spans biopharma product testing, environmental testing, food testing across 27 labs; about 750 FTEs.
• Unit expected to generate annual revenue above USD 150 million in 2026; profitability expected to be in line with Eurofins’ group average.
• Deal expected to close in Q4 2026, subject to customary conditions including regulatory approvals.
• Transaction aimed at expanding Eurofins’ North American lab footprint into underrepresented US and Canadian regions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eurofins Scientific SE published the original content used to generate this news brief via Business Wire (Ref. ID: 20260719989224) on July 20, 2026, and is solely responsible for the information contained therein.